EU Panel Review Supports Decision to Pull Picato From Market EU Panel Review Supports Decision to Pull Picato From Market
A European Medicines Agency safety committee concluded that the risks for skin cancer from the topical gel used to treat actinic keratosis outweigh the benefits.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Dermatology | European Medicines Agency (EMA) | Health | Skin | Skin Cancer